156 related articles for article (PubMed ID: 26554540)
1. Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non-cancer tissue.
Yang Q; Zhao J; Cui M; Gi S; Wang W; Han X
J Obstet Gynaecol Res; 2015 Dec; 41(12):1959-64. PubMed ID: 26554540
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient.
Gao C; Pang L; Ren C; Ma T
Med Oncol; 2012 Sep; 29(3):1733-8. PubMed ID: 21909941
[TBL] [Abstract][Full Text] [Related]
3. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
[TBL] [Abstract][Full Text] [Related]
4. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
5. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
8. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
9. Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer.
Mei L; Hu Q; Peng J; Ruan J; Zou J; Huang Q; Liu S; Wang H
Int J Clin Exp Pathol; 2015; 8(5):5597-602. PubMed ID: 26191270
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
Shuang T; Wang M; Zhou Y; Shi C
Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
[TBL] [Abstract][Full Text] [Related]
11. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer.
Song IH; Kim KR; Lim S; Kim SH; Sung CO
Pathol Res Pract; 2018 Oct; 214(10):1564-1571. PubMed ID: 30082157
[TBL] [Abstract][Full Text] [Related]
14. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer.
Zhou S; Tang L; Wang H; Dai J; Zhang J; Shen L; Ng SW; Berkowitz RS
Gynecol Oncol; 2013 Oct; 131(1):69-76. PubMed ID: 23820113
[TBL] [Abstract][Full Text] [Related]
16. miR-93 promotes TGF-β-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.
Qu MH; Han C; Srivastava AK; Cui T; Zou N; Gao ZQ; Wang QE
Tumour Biol; 2016 Apr; 37(4):5645-51. PubMed ID: 26581907
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 serves as a marker for the progression of epithelial ovarian carcinoma.
Guo Q; Yang X; Ma Y; Ma L
Eur J Gynaecol Oncol; 2015; 36(5):506-13. PubMed ID: 26513873
[TBL] [Abstract][Full Text] [Related]
18. Decreased semaphorin 3A expression is associated with a poor prognosis in patients with epithelial ovarian carcinoma.
Jiang H; Qi L; Wang F; Sun Z; Huang Z; Xi Q
Int J Mol Med; 2015 May; 35(5):1374-80. PubMed ID: 25812535
[TBL] [Abstract][Full Text] [Related]
19. High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells.
Zhao Z; Xu Y; Lu J; Xue J; Liu P
Clin Transl Oncol; 2018 Apr; 20(4):491-499. PubMed ID: 28808929
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
